MX381723B - Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa. - Google Patents

Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa.

Info

Publication number
MX381723B
MX381723B MX2017007503A MX2017007503A MX381723B MX 381723 B MX381723 B MX 381723B MX 2017007503 A MX2017007503 A MX 2017007503A MX 2017007503 A MX2017007503 A MX 2017007503A MX 381723 B MX381723 B MX 381723B
Authority
MX
Mexico
Prior art keywords
seq
sortase
enzyme
novel methods
polypeptide
Prior art date
Application number
MX2017007503A
Other languages
English (en)
Other versions
MX2017007503A (es
Inventor
Mara Boenitz-Dulat
Martin Schatte
Peter Kratzsch
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2017007503A publication Critical patent/MX2017007503A/es
Publication of MX381723B publication Critical patent/MX381723B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/2207—Sortase A (3.4.22.70)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

La presente invención se refiere a un método para producir un producto de conjugación enzimática de dos polipéptidos caracterizado porque comprende los siguientes pasos -incubar i) un primer polipéptido que comprende la secuencia de aminoácidos LPXTG de SEC ID NO: 20, en donde X puede ser cualquier residuo de aminoácido, ii) un segundo polipéptido que comprende i) un compuesto de alaninilo en su extremo N-terminal, o ii) una oligo-alanina Am con m = 2 de SEC ID NO: 26, o 3 de SEC ID NO: 27, o 4 de SEQ ID NO: 28, O 5 DE SEQ ID NO: 29, o iii) un residuo de aminoácido de cisteína seguido por uno o tres residuos de aminoácidos de alanina en su extremo N-terminal, iii) un tercer polipéptido con actividad sortasa que se deriva de sortasa A de Staphylococcus aureus, y recuperar el conjugado de la mezcla de reacción y de este modo producir el producto de conjugación enzimática de dos polipéptidos.
MX2017007503A 2014-12-17 2015-12-14 Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa. MX381723B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14198532 2014-12-17
PCT/EP2015/079617 WO2016096741A1 (en) 2014-12-17 2015-12-14 Novel methods for enzyme mediated polypeptide conjugation using sortase

Publications (2)

Publication Number Publication Date
MX2017007503A MX2017007503A (es) 2017-10-04
MX381723B true MX381723B (es) 2025-03-13

Family

ID=52338848

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007503A MX381723B (es) 2014-12-17 2015-12-14 Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa.

Country Status (11)

Country Link
US (1) US10190182B2 (es)
EP (1) EP3233905B1 (es)
JP (1) JP6618539B2 (es)
KR (1) KR20170094216A (es)
CN (1) CN107001447B (es)
BR (1) BR112017010775A2 (es)
CA (1) CA2966287A1 (es)
MX (1) MX381723B (es)
RU (1) RU2714963C2 (es)
SG (1) SG11201704625UA (es)
WO (1) WO2016096741A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106191015B (zh) * 2016-08-25 2019-09-13 北京大学 金黄色葡萄球菌分选酶a高效突变体
WO2022166913A1 (en) * 2021-02-04 2022-08-11 Westlake Therapeutics (Hangzhou) Co. Limited Modified red blood cells and uses thereof for treating hyperuricemia and gout
CN118786207A (zh) * 2022-01-12 2024-10-15 西湖生物医药科技(上海)有限公司 经修饰的细胞及其用途
CN114487409B (zh) * 2022-04-14 2022-07-19 启德医药科技(苏州)有限公司 一种转肽酶活性的检测方法及检测试剂盒
CN116949004B (zh) * 2023-07-13 2024-04-09 苏州源启生物科技有限公司 一种转肽酶Sortase A及其制备方法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150149A (en) 1976-11-29 1979-04-17 Professional Staff Association Of The Los Angeles County Harbor General Hospital Method and means for the early detection and diagnosis of certain types of cancers
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4444744A (en) 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens
US4361544A (en) 1980-03-03 1982-11-30 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US5342606A (en) 1984-10-18 1994-08-30 Board Of Regents, The University Of Texas System Polyazamacrocyclic compounds for complexation of metal ions
US5316757A (en) 1984-10-18 1994-05-31 Board Of Regents, The University Of Texas System Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
EP0604580A1 (en) 1991-09-19 1994-07-06 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES
US5428139A (en) 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
US5739294A (en) 1991-12-10 1998-04-14 The Dow Chemical Company Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
US5480990A (en) 1991-12-10 1996-01-02 The Dow Chemical Company Bicyclopolyazamacrocyclocarboxylic acid complexes for use as contrast agents
ZA932522B (en) 1992-04-10 1993-12-20 Res Dev Foundation Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens
ATE139900T1 (de) 1992-11-13 1996-07-15 Idec Pharma Corp Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
US5385893A (en) 1993-05-06 1995-01-31 The Dow Chemical Company Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
US5462725A (en) 1993-05-06 1995-10-31 The Dow Chemical Company 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
US5834456A (en) 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
US6528624B1 (en) 1998-04-02 2003-03-04 Genentech, Inc. Polypeptide variants
KR100797667B1 (ko) 1999-10-04 2008-01-23 메디카고 인코포레이티드 외래 유전자의 전사를 조절하는 방법
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
US20100111856A1 (en) 2004-09-23 2010-05-06 Herman Gill Zirconium-radiolabeled, cysteine engineered antibody conjugates
CN101490087B (zh) * 2006-05-30 2013-11-06 健泰科生物技术公司 抗体和免疫偶联物及其用途
US8940501B2 (en) * 2009-01-30 2015-01-27 Whitehead Institute For Biomedical Research Methods for ligation and uses thereof
EP2403530B1 (en) 2009-02-27 2016-05-11 Massachusetts Institute of Technology Engineered proteins with high affinity for dota chelates
EP2726494B1 (en) 2011-06-28 2017-01-04 Whitehead Institute For Biomedical Research Using sortases to install click chemistry handles for protein ligation
ES2597228T3 (es) * 2012-06-27 2017-01-17 F. Hoffmann-La Roche Ag Procedimiento para la selección y la producción de entidades de objetivación, como dianas, altamente selectivas y multiespecíficas, personalizadas, las cuales contienen por lo menos dos entidades de unión diferentes, y utilización de éstas

Also Published As

Publication number Publication date
RU2017122029A (ru) 2019-01-17
CA2966287A1 (en) 2016-06-23
US10190182B2 (en) 2019-01-29
SG11201704625UA (en) 2017-07-28
RU2017122029A3 (es) 2019-07-17
JP2018500901A (ja) 2018-01-18
US20170292166A1 (en) 2017-10-12
JP6618539B2 (ja) 2019-12-11
EP3233905A1 (en) 2017-10-25
MX2017007503A (es) 2017-10-04
KR20170094216A (ko) 2017-08-17
EP3233905B1 (en) 2020-01-29
WO2016096741A1 (en) 2016-06-23
CN107001447B (zh) 2021-07-23
RU2714963C2 (ru) 2020-02-21
BR112017010775A2 (pt) 2018-02-27
CN107001447A (zh) 2017-08-01

Similar Documents

Publication Publication Date Title
PH12017500785A1 (en) INTERFERON a2B VARIANTS
EA201490447A1 (ru) Эндогликозидаза из streptococcus pyogenes и способы с применением указанной эндогликозидазы
MY176331A (en) Carbohydrate degrading polypeptide and uses thereof
WO2015027258A3 (de) Polypeptid zur hydrolytischen spaltung von zearalenon und/oder zearalenon-derivaten, isoliertes polynukleotid davon sowie einen zusatzstoff enthaltendes polypeptid, verwendung desselben sowie verfahren
MX2022005119A (es) Metodos de reduccion de olor.
MX382218B (es) Variantes de lipasa y polinucleotidos que las codifican.
AU2015212749A8 (en) Protein
WO2015181119A3 (en) Lipase variants and polynucleotides encoding same
MX2017005642A (es) Anticuerpos anti-angiopoyetina 2 (ang2) y metodos de uso.
EP4374913A3 (en) Novel human serum albumin mutant
WO2016035007A3 (en) An improved process for the preparation of apixaban and intermediates thereof
EP2533792A4 (en) CHEMICAL PREPARATION OF POLYUBIQUITINE CHAINS
MX2015001542A (es) Metodo.
MY169049A (en) Microorganisms for producing putrescine and process for producing putrescine using them
AU2015344324A8 (en) Endoxylanase mutant, enzyme composition for biomass decomposition, and method for producing sugar solution
MX2017007503A (es) Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa.
SG195302A1 (en) Shk-based pharmaceutical compositions and methods of manufacturing and using the same
EP4043558A3 (en) Kaurenoic acid hydroxylases
MY187334A (en) Xylanase
MX376535B (es) Reacción enzimática en un solo recipiente para conjugación de polipéptido doble en un solo paso usando sortasa.
CA2909744C (en) Protransduzin b, an enhancer of gene transfer
MX395506B (es) CICLASA DE TETRAPRENIL-ß-CURCUMENO MUTADA Y MÉTODO PARA PRODUCIR AMBREÍNA.
WO2015127365A3 (en) Calcium-independent sortase a mutants
MX2017012733A (es) Produccion de compuestos fragantes.
WO2017174769A3 (en) Detergent compositions and uses of the same